請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/83671完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 胡文聰 | zh_TW |
| dc.contributor.advisor | Andrew M. Wo | en |
| dc.contributor.author | 張正玟 | zh_TW |
| dc.contributor.author | Jheng-Wun Chang | en |
| dc.date.accessioned | 2023-03-19T21:13:43Z | - |
| dc.date.available | 2023-12-25 | - |
| dc.date.copyright | 2022-08-19 | - |
| dc.date.issued | 2022 | - |
| dc.date.submitted | 2002-01-01 | - |
| dc.identifier.citation | 1.Hofmann, L., et al., The emerging role of exosomes in diagnosis, prognosis, and therapy in head and neck cancer. International journal of molecular sciences, 2020. 21(11): p. 4072.
2.Rufino-Ramos, D., et al., Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases. Journal of Controlled Release, 2017. 262: p. 247-258. 3.Kalluri, R. and V.S. LeBleu, The biology, function, and biomedical applications of exosomes. Science, 2020. 367(6478): p. eaau6977. 4.Raposo, G. and W. Stoorvogel, Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol, 2013. 200(4): p. 373-83. 5.Lai, J.J., et al., Exosome Processing and Characterization Approaches for Research and Technology Development. Advanced Science, 2022: p. 2103222. 6.Chen, Q.Y., et al., Exosomal Proteins and miRNAs as Mediators of Amyotrophic Lateral Sclerosis. Front Cell Dev Biol, 2021. 9: p. 718803. 7.Valadi, H., et al., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature cell biology, 2007. 9(6): p. 654-659. 8.Van Niel, G., et al., Exosomes: a common pathway for a specialized function. Journal of biochemistry, 2006. 140(1): p. 13-21. 9.Chen, X., et al., Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res, 2008. 18(10): p. 997-1006. 10.Mitchell, P.S., et al., Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences, 2008. 105(30): p. 10513-10518. 11.Domenyuk, V., et al., Plasma exosome profiling of cancer patients by a next generation systems biology approach. Scientific reports, 2017. 7(1): p. 1-15. 12.Kim, B., G.O. Noh, and K. Kim, Behavioural and psychological symptoms of dementia in patients with Alzheimer’s disease and family caregiver burden: a path analysis. BMC geriatrics, 2021. 21(1): p. 1-12. 13.Zhang, T., et al., The emerging role of exosomes in Alzheimer’s disease. Ageing research reviews, 2021. 68: p. 101321. 14.Pérez, M., J. Avila, and F. Hernández, Propagation of tau via extracellular vesicles. Frontiers in Neuroscience, 2019. 13: p. 698. 15.Rajendran, L., et al., Alzheimer's disease β-amyloid peptides are released in association with exosomes. Proceedings of the National Academy of Sciences, 2006. 103(30): p. 11172-11177. 16.Saman, S., et al., Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. Journal of biological chemistry, 2012. 287(6): p. 3842-3849. 17.Jia, L., et al., Concordance between the assessment of Aβ42, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid. Alzheimer's & Dementia, 2019. 15(8): p. 1071-1080. 18.Sun, R., et al., A pilot study of urinary exosomes in Alzheimer’s disease. Neurodegenerative Diseases, 2019. 19(5-6): p. 184-191. 19.Rani, K., et al., A novel approach to correlate the salivary exosomes and their protein cargo in the progression of cognitive impairment into Alzheimer’s disease. Journal of neuroscience methods, 2021. 347: p. 108980. 20.Fiandaca, M.S., et al., Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case‐control study. Alzheimer's & Dementia, 2015. 11(6): p. 600-607. e1. 21.Congdon, E.E. and E.M. Sigurdsson, Tau-targeting therapies for Alzheimer disease. Nature Reviews Neurology, 2018. 14(7): p. 399-415. 22.Liangsupree, T., E. Multia, and M.-L. Riekkola, Modern isolation and separation techniques for extracellular vesicles. Journal of Chromatography A, 2021. 1636: p. 461773. 23.Royo, F., et al., Methods for separation and characterization of extracellular vesicles: results of a worldwide survey performed by the ISEV rigor and standardization subcommittee. Cells, 2020. 9(9): p. 1955. 24.Zhang, M., et al., Methods and technologies for exosome isolation and characterization. Small Methods, 2018. 2(9): p. 1800021. 25.Chen, J., et al., Review on strategies and technologies for exosome isolation and purification. Frontiers in Bioengineering and Biotechnology, 2022. 9: p. 811971. 26.Mathieu, M., et al., Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nature cell biology, 2019. 21(1): p. 9-17. 27.Amiri, A., et al., Exosomes as bio-inspired nanocarriers for RNA delivery: Preparation and applications. Journal of Translational Medicine, 2022. 20(1): p. 1-16. 28.Sidhom, K., P.O. Obi, and A. Saleem, A review of exosomal isolation methods: is size exclusion chromatography the best option? International Journal of Molecular Sciences, 2020. 21(18): p. 6466. 29.Rider, M.A., S.N. Hurwitz, and D.G. Meckes, ExtraPEG: a polyethylene glycol-based method for enrichment of extracellular vesicles. Scientific reports, 2016. 6(1): p. 1-14. 30.Lee, J.C., et al., Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers. Experimental & molecular medicine, 2019. 51(5): p. 1-10. 31.De Toro, J., et al., Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications. Frontiers in immunology, 2015. 6: p. 203. 32.Soliman, H.M., et al., Exosomes in Alzheimer’s disease: from being pathological players to potential diagnostics and therapeutics. International Journal of Molecular Sciences, 2021. 22(19): p. 10794. 33.Malm, T., S. Loppi, and K.M. Kanninen, Exosomes in Alzheimer's disease. Neurochemistry international, 2016. 97: p. 193-199. 34.Canning, P., et al., Perspectives and Challenges on the Potential Use of Exosomes in Bioartificial Pancreas Engineering. Annals of Biomedical Engineering, 2022: p. 1-10. 35.Keerthikumar, S., et al., ExoCarta: a web-based compendium of exosomal cargo. Journal of molecular biology, 2016. 428(4): p. 688-692. 36.Gaugler, J., et al., 2022 Alzheimer's disease facts and figures. ALZHEIMERS & DEMENTIA, 2022. 18(4): p. 700-789. 37.Andreasen, N., et al., Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice. Archives of neurology, 2001. 58(3): p. 373-379. 38.Ferreira, D., et al., Meta-review of CSF core biomarkers in Alzheimer’s disease: the state-of-the-art after the new revised diagnostic criteria. Frontiers in aging neuroscience, 2014. 6: p. 47. 39.Holtzman, D.M., CSF biomarkers for Alzheimer's disease: current utility and potential future use. Neurobiology of aging, 2011. 32: p. S4-S9. 40.Gu, D., et al., Elevated matrix metalloproteinase‐9 levels in neuronal extracellular vesicles in Alzheimer’s disease. Annals of Clinical and Translational Neurology, 2020. 7(9): p. 1681-1691. 41.Janelidze, S., et al., Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease. Nature communications, 2020. 11(1): p. 1-12. 42.Wennström, M., et al., Cellular localization of p-tau217 in brain and its association with p-tau217 plasma levels. Acta neuropathologica communications, 2022. 10(1): p. 1-12. 43.Palmqvist, S., et al., Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. Jama, 2020. 324(8): p. 772-781. 44.Raposo, G., et al., B lymphocytes secrete antigen-presenting vesicles. The Journal of experimental medicine, 1996. 183(3): p. 1161-1172. 45.Momen-Heravi, F., et al., Current methods for the isolation of extracellular vesicles. Biological chemistry, 2013. 394(10): p. 1253-1262. | - |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/83671 | - |
| dc.description.abstract | 外泌體為奈米外囊泡,粒徑大小約為30-150nm,,外層為脂質雙層膜構造,膜內攜帶多種訊號因子,包含蛋白質、醣類、核酸等,並傳遞訊號到其他細胞,扮演著細胞之間溝通的重要角色,由於大部分的細胞都可分泌外泌體,加上在許多體液中皆可發現外泌體的存在,因此成為非侵入式液態活檢的研究對象,近年來,許多文獻指出外泌體攜帶疾病相關的生物資訊,並且應用在疾病的診斷及追蹤。
本研究利用密度梯度離心法純化血液中的外泌體,結合疾病的生物標記,應用在退化性疾病上。研究結果提供血液中外泌體可以作診斷潛在生物標記之初步證據,實驗數據表示在疾病相關蛋白之表現,在統計上有一定的差異。所以,疾病蛋白之表現應該有潛力應用在檢測,然而需要更多的檢體量以驗證在臨床上的實際應用,期望未來能運用外泌體確實作為疾病之檢測。 | zh_TW |
| dc.description.abstract | Exosomes are nanosized vesicles with a diameter of 30-150 nm, encapsulated by lipid bilayer carrying proteins, lipids, and nucleic acids. The past decade has seen strong support that exosomes effectively deliver message to recipient cells and participate in cell-to-cell communication network. Furthermore, they have the ability to inherit various specific biological molecules from parent cells and reflect the pathological conditions when difference occurs in their composition. Recently, many studies indicated that exosomes have a relevant role in disease pathogenesis. In this study, we isolated exosomes by sucrose density gradient centrifugation and applied in neurodegenerative disease. The findings provided support for the notion that plasma-derived exosomes might perform as potential biomarkers of diagnosis in disease management. Future work requires further confirmation with additional clinical samples. | en |
| dc.description.provenance | Made available in DSpace on 2023-03-19T21:13:43Z (GMT). No. of bitstreams: 1 U0001-1708202212155500.pdf: 4146633 bytes, checksum: e1c02ab9103d2245282af3a005f341e1 (MD5) Previous issue date: 2022 | en |
| dc.description.tableofcontents | 口試檢定 i
致謝 ii 中文摘要 iii Abstract iv Table of Contents v List of Figures vi List of Tables vii Chapter 1. Introduction 1 1.1 Introduction of exosomes 1 1.2 Exosome as diagnostic biomarker for disease 3 1.3 The emerging role of exosome in Alzheimer’s disease 4 1.4 Exosomes derived from blood 6 1.5 Common exosomal isolation methods 8 1.5.1 Ultracentrifugation 8 1.5.2 Ultrafiltration 10 1.5.3 Size exclusion chromatography (SEC) 11 1.5.4 Immunoaffinity 12 1.5.5 Polymer precipitation 13 1.6 The purpose of this study 14 Chapter 2. Materials and Methods 16 2.1 Preparation of blood plasma 16 2.2 Isolation of plasma-derived exosomes with ultracentrifugation 17 2.3 Antibodies in this study 19 2.4 Isolation of exosomes by size exclusion chromatography 21 2.5 Isolation of exosomes by density gradient centrifugation 22 2.6 Enzyme-linked immunosorbent assay (ELISA) 24 2.7 Statistical analysis 25 Chapter 3. Results 26 3.1 Antibody for exosomal marker selection 26 3.2 Optimization of plasma concentration for density gradient centrifugation 31 3.3 Identification of exosomes from density gradient fractions 33 3.4 Finding the suitable dilution ratio on different markers 36 3.5 AD associated biomarkers in plasma derived exosome 38 Chapter 4. Discussion 41 Chapter 5. Conclusions 43 References 44 | - |
| dc.language.iso | en | - |
| dc.subject | 疾病檢測 | zh_TW |
| dc.subject | 外泌體 | zh_TW |
| dc.subject | 密度梯度離心法 | zh_TW |
| dc.subject | 疾病檢測 | zh_TW |
| dc.subject | 外泌體 | zh_TW |
| dc.subject | 密度梯度離心法 | zh_TW |
| dc.subject | disease diagnostic | en |
| dc.subject | exosome | en |
| dc.subject | density gradient centrifugation | en |
| dc.subject | disease diagnostic | en |
| dc.subject | exosome | en |
| dc.subject | density gradient centrifugation | en |
| dc.title | 密度梯度離心法純化外泌體之研究 | zh_TW |
| dc.title | Purification of Exosomes in Plasma via Density Gradient Centrifugation | en |
| dc.type | Thesis | - |
| dc.date.schoolyear | 110-2 | - |
| dc.description.degree | 碩士 | - |
| dc.contributor.oralexamcommittee | 李雨;許聿翔 | zh_TW |
| dc.contributor.oralexamcommittee | U Lei;Yu-Hsiang Hsu | en |
| dc.subject.keyword | 外泌體,密度梯度離心法,疾病檢測, | zh_TW |
| dc.subject.keyword | exosome,density gradient centrifugation,disease diagnostic, | en |
| dc.relation.page | 47 | - |
| dc.identifier.doi | 10.6342/NTU202202492 | - |
| dc.rights.note | 未授權 | - |
| dc.date.accepted | 2022-08-17 | - |
| dc.contributor.author-college | 工學院 | - |
| dc.contributor.author-dept | 應用力學研究所 | - |
| 顯示於系所單位: | 應用力學研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-110-2.pdf 未授權公開取用 | 4.05 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
